About Clinigen
Clinigen is a Healthcare company based in Burton Upon Trent (United Kingdom) founded in 2010, and was acquired by Triton Partners in December 2021. Specialty medicines are supplied via clinical trials and access programs. Clinigen has completed 11 acquisitions, including Clinical Supplies Management, Drug Safety Navigator and IDIS Pharma. Its chief executive, as recorded, is Jerome Charton. Its website clinigengroup.com draws about 18 thousand monthly visits. Clinigen offers products and services including Clinical Trial Supplies, Managed Access Programs, and Regulatory Affairs. Its focus areas include Biopharma Outsourcing, Consulting and Diversified. Its legal entity is CLINIGEN LIMITED. Its competitors include Science Group and Diaceutics.
Company details
Clinigen Group was founded in 2010 and is based in Burton-on-Trent, United Kingdom. Operations are conducted in the specialty pharmaceutical and services sector through five businesses. Medicines are delivered to patients using clinical trials, licensed channels, and unlicensed pathways. Services encompass trial supplies, managed access to investigational drugs, global availability of approved medicines in limited regions, supply continuity for healthcare providers, and regional distribution of specialist products.
- Headquarters Burton Upon Trent, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website clinigengroup.com
- Social LinkedIn X
- Acquired by Triton Partners (Dec 2021)
- Legal Name Clinigen Limited
- Date of Incorporation 12 Dec, 2008
- Jurisdiction BURTON ON TRENT, STAFFORDSHIRE
- Investors
- Investments & AcquisitionsClinical Supplies Management
& 10 more
- Acquired byTriton Partners
(Dec 2021)
Products & Services of Clinigen
Clinigen offers a comprehensive portfolio of products and services, including Clinical Trial Supplies, Managed Access Programs, and Regulatory Affairs.
Services for sourcing, packaging, and distribution in clinical trials.
Programs for early access to innovative medicines for patients globally.
Support for pharmacovigilance and regulatory processes in medicine access.
Investors in Clinigen
Clinigen has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Triton Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and debt fund focused on service, healthcare, consumer, and industrial sectors | 1997 | triton-partners.com | London, United Kingdom |
Investor details for Clinigen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Clinigen
63 people are tracked at Clinigen (28 in leadership, 3 in board & advisors, 32 in team).
| Name | Role | Group |
|---|---|---|
Jerome Charton | CEO | Leadership |
Jackie Kavanagh | Head Of Transformation Office | Leadership |
Mark Ashton-Blanksby | VP Commercial Finance | Leadership |
Lauren Heiser | Business Development Director | Leadership |
Dr. Sumit Banerjee | Business Development Director Japac | Leadership |
Henrik Schlieker | Director, Business Development, Global Business Development | Leadership |
Keith Byrne | Group Head Of Corporate Development | Leadership |
Pete Solman | Commercial Development Director | Leadership |
Nicky Wisener | Vice President, Business Development, Unlicensed Medicines | Leadership |
Anna Harrison | Senior HR Business Partner | Leadership |
John Denier | Global Director Of Business Development - Clinical Trial Services | Leadership |
Toni Williams | Global Business Development Director | Leadership |
Katharine Tipper | Client Director | Leadership |
Jenny Pearce | VP Client Delivery | Leadership |
Dan Wasserstrom | Sr Director Of Business Development | Leadership |
Toby S. | Global Portfolio Director - Brands | Leadership |
Dries de Doncker | Vice President Sourcing And Procurement | Leadership |
Jules Shale | Commercial Development Director | Leadership |
Barbara MacKey | VP Corporate Development | Leadership |
Thomas Hindle | Strategic Sourcing Director | Leadership |
43 more people are available in the full profile.
Complete people profiles for Clinigen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clinigen
Clinigen has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include Clinical Supplies Management, Drug Safety Navigator and IDIS Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmacovigilance and medical affairs services are offered for drug development. | ssistrategy.com | Parsippany Troy Hills, United States | 2010 | Sep 2025 | •••• | |
Provider of strategic development, regulatory affairs, and consultancy services for the biotech and pharmaceutical sectors | kinesysconsulting.com | Glasgow, United Kingdom | 2007 | Aug 2024 | •••• | |
Regulatory affairs, quality control, and medical monitoring services are provided. | drugsafetynavigator.com | Durham, United States | 2012 | Nov 2022 | •••• | |
Technologically advanced theme parks are developed with immersive attractions. | csmondemand.com | West Fargo, United States | 1997 | Sep 2018 | $150M | |
Provider of biosimilar and breakthrough medicines distribution | iqone-healthcare.com | Versoix, Switzerland | 1979 | Sep 2018 | $8.82M | |
Unlicensed medicines are manufactured for various applications. | quantumpharmaceutical.co.uk | Durham, United Kingdom | 2004 | Dec 2017 | $176.67M | |
Medical supply consulting services are provided to healthcare providers. | imm-c.com | Tokyo, Japan | 2006 | Oct 2017 | •••• | |
Manufacturer of drugs | quantumpharmagroup.com | Durham, United Kingdom | 2004 | Sep 2017 | $198.62M | |
Anthracycline extravasation antidote is provided by Totect. | totect.com | Nashville, United States | 2005 | Mar 2016 | •••• | |
Specialty drugs are distributed by Link Healthcare in Australia. | linkhealthcare.com.au | Sydney, Australia | 1997 | Sep 2015 | $69.08M |
Complete acquisition details for Clinigen
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Clinigen
13 dated milestones of Clinigen across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Clinigen is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Link Healthcare.
- Acquisition Acquires Totect.
- Acquisition Acquires Quantum Pharma Group.
- Acquisition Acquires IMMC.
- Acquisition Acquires Quantum Pharmaceutical.
- Acquisition Acquires iQone Healthcare Group.
- Acquisition Acquires Clinical Supplies Management.
- Exit Acquired by Triton Partners.
- Acquisition Acquires Drug Safety Navigator.
- Acquisition Acquires Kinesys Consulting.
- Acquisition Acquires SSI Strategy.
Competitors of Clinigen
Clinigen has 2 listed competitors in our database. They include Science Group and Diaceutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sciencegroup.com | 1995 | Cambridge, United Kingdom | 431 | Technology-based consultancy and product development services are provided. | ||
| diaceutics.com | 2005 | Belfast, United Kingdom | 133 | Precision medicine integration is facilitated through analytics and services. |
Detailed competitors of Clinigen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Clinigen
The website of Clinigen (clinigengroup.com) receives about 17.9K visits a month and ranks #1,447,669 among all websites worldwide, #1,882 in Biotechnology and Pharmaceuticals.
- Monthly visits17.9K
▲ 14.8% vs previous month
- Unique visitors6.4K
per month
- Global rank#1,447,669
among all websites
- Category rank#1,882
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit2.6
- Average visit32 sec
- DevicesDesktop 31% · Mobile 69%
Websites whose visitors overlap most with Clinigen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| imperialcrs.com | 100% | #2,528,272 | View details | ||
pharmaceuticalmanufacturer.media | pharmaceuticalmanufacturer.media | 99% | #1,499,999 | – | |
| biocair.com | 94% | 17.8K | #1,235,882 | View details | |
| precisionformedicine.com | 92% | 36.8K | #1,000,701 | View details | |
| syngeneintl.com | 88% | 94K | #525,515 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Clinigen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Clinigen
Complete news archive for Clinigen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clinigen
Clinigen was founded in 2010.
Clinigen is headquartered in Burton Upon Trent, United Kingdom. It is registered at Burton Upon Trent, England, United Kingdom.
Jerome Charton is the CEO of Clinigen, as recorded in our data.
Clinigen Group was founded in 2010 and is based in Burton-on-Trent, United Kingdom. Operations are conducted in the specialty pharmaceutical and services sector through five businesses. Medicines are delivered to patients using clinical trials, licensed channels, and unlicensed pathways. Services encompass trial supplies, managed access to investigational drugs, global availability of approved medicines in limited regions, supply continuity for healthcare providers, and regional distribution of specialist products.
Clinigen's top competitors include Diaceutics and Science Group.
Clinigen offers Clinical Trial Supplies, Managed Access Programs, and Regulatory Affairs.
Clinigen has made 11 acquisitions, including Clinical Supplies Management, Drug Safety Navigator, and IDIS Pharma.
Clinigen has 1 investor. Key investors include Triton Partners.
Clinigen operates through Clinigen Limited.
Yes. Clinigen was acquired by Triton Partners in December 2021.